# Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation

> **NCT00302627** · NA · COMPLETED · sponsor: **Providence Health & Services** · enrollment: 43 (actual)

## Conditions studied

- Transplant Bone Disease

## Interventions

- **DRUG:** Pamidronate
- **DRUG:** vitamin D
- **DRUG:** Calcium Carbonate

## Key facts

- **NCT ID:** NCT00302627
- **Lead sponsor:** Providence Health & Services
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2002-11
- **Final completion:** 2002-11
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-08-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302627, "Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00302627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*